Skip to main content

Table 1 Patient Characteristics

From: The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia

Characteristic De novo AML patients AML patients in 1stCR
Patients,no. 48 40
Sex,male/female,no.(%) 31(65)/17(35) 24(60)/16(40)
Median age,y(range) 41(14–74) 41(14–68)
WBC count (10 9 /L)
Median 46.3 6.3
Range 0.8-354.9 2.6-10.2
Hemoglobin (g/dL)
Median 7.7 11.8
Range 4.1-13.2 8.3-16.1
Platelet count (10 9 /L)
Median 58 243.3
Range 2-319 76-384
BM blasts (%)
Median 69.1 2.1
Range (24–96) (0–5)
FAB subtype,n/(%)
M2 9/(19) 6/(15)
M3 11/(23) 20/(50)
M4 11/(23) 8/(20)
M5 15/(31) 5/(12.5)
M6 2/(4) 1/(2.5)